Management

Piramal Life starts trial of new diabetes drug

Piramal Life Sciences has commenced phase I trial of a new experimental drug molecule P2202 for diabetes metabolic syndrome in Canada. P2202 is the second compound from Eli Lilly and is part of the collaborative agreement between two companies and is being developed for diabetes metabolic syndrome. - Dr Reddy"s to invest Rs 750 crore in two SEZs - Rising rupee could help Ranbaxy negate loss in Q2 - Piramal Life Sciences to invest Rs 200 cr in R&D - Novartis open offer to begin on May 20 - Ranbaxy seeks govt nod for excess pay to directors - Piramal Life up on clinical-trial nod The metabolic syndrome is characterised by a group of metabolic risk factors such as abdominal obesity, blood fat disorders that foster plaque build ups in artery walls, elevated blood pressure, insulin resistance and pro-inflammatory state. People with metabolic syndrome are at increased risk of coronary heart disease, stroke and type 2 diabetes. P2202 is being developed for the treatment of metabolic disorders. Piramal Life Sciences had submitted the clinical trial application for P2202 to Health Canada, Canada"s regulatory authority. This body has approved company"s application to initiate phase I study of P2202.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Cars won't all shrink under Obama's fuel plan, automakers say
Automakers say they won’t have to overhaul their technology or flood the US with tiny cars buyers may not want under President Barack Obama’s standards for fuel economy and greenhouse-gas emissions.
Popular Articles
payday loans

17,370 critical for upside
The stock market was volatile and moved in a narrow range during the week. Global cues were mostly subdued, and news flows were largely positive, resulting in limited downsides on weak days. However, the indices failed to give a clear breakout on the upside as well.

Reddy autopsy report to be handed over to probe agencies
The autopsy reports of former Andhra Pradesh Chief Minister Y S Rajasekhara Reddy and four others killed in the chopper crash will be handed over to CB (CID) and Directorate of Civil Aviation probing the mishap.

© Copyright 2009